Results
eNauka >
Results >
Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer The VIABLE Phase 3 Randomized Clinical Trial
| Title: | Efficacy and Safety of Autologous Dendritic Cell-Based Immunotherapy, Docetaxel, and Prednisone vs Placebo in Patients With Metastatic Castration-Resistant Prostate Cancer The VIABLE Phase 3 Randomized Clinical Trial | Authors  : | Vogelzang, Nicholas J; ...; Filipovic, Zoran; ...; (broj, koautora 26) | Issue Date: | 2022 | Publication: | JAMA ONCOLOGY | ISSN: | 2374-2437 JAMA Oncology Search Idenfier |
Type: | Article | Collation: | vol. 8 br. 4 str. 546-546 | DOI: | 10.1001/jamaoncol.2021.7298 | WoS-ID: | 000754028300007 | Scopus-ID: | 2-s2.0-85125043224 | PMID: | 35142815 | PMCID: | PMC8832307 | URI: | https://enauka.gov.rs/handle/123456789/828066 | Project: | Sotio a.s. | Metadata source: | (Preuzeto iz Nasi u WoS) | M-category: | 21a+M21a+ |
Items in eNauka are protected by copyright, with all rights reserved, unless otherwise indicated.